Author

Qiyan Wang

Northwest A&F University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Genomics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Approach:machine learning (classical)· 1 Organism:mouse· 1 Assay:proteomics· 1 Research Focus:variant calling· 1 Assay:whole-genome sequencing· 1

Frequent Co-Authors

Ali Mujtaba ShahiD· 1 shared Ao WangiD· 1 shared Bo WeniD· 1 shared Chunpeng Yang· 1 shared Duxin SuniD· 1 shared Furong ChengiD· 1 shared G.L. Liu· 1 shared Guizhi ZhuiD· 1 shared

Activity by Year

2024-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenomics

Ali Mujtaba ShahORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cost-effective genomic prediction for fertility traits: A comparison of machine learning and conventional models using low-coverage sequencing in Holstein heifers

Zhuangbiao Zhang, Ao Wang, Qiyan Wang, S.Q. Gao, L.L. Wang, Honghong Hu, Hojjat Asadollahpour Nanaei, Ali Mujtaba Shah, G.L. Liu, K. Zhu, X.Z. Lv, R. Li, Yu Yan Jiang

This study compares machine learning and conventional models for genomic prediction of fertility traits in Holstein heifers using low-coverage sequencing data, finding that KRR_GRM improves accuracy over traditional methods when using only genomic data.

animal · Apr 24, 2026Peer-reviewedGenomics

Proteolysis-targeting vaccines (PROTAVs) for robust combination immunotherapy of melanoma

Qiyan Wang, Ting Su, Furong Cheng, Shurong Zhou, Xiang Liu, Mi Wang, You Xu, Ri Tang, Shimiao Liao, Jordan M. Dailey, Guolan Xiao, Chunpeng Yang, Hanning Wen, Weijia Zheng, Bo Wen, , Guizhi Zhu

This paper introduces PROTAVs, a new vaccine strategy that enhances T cell responses and combination immunotherapy for melanoma by improving antigen processing and cross-presentation.

bioRxiv · Oct 1, 2024 · PreprintBioengineering